載入...
Does tumor size predict response to neoadjuvant chemotherapy in the modern era of biologically driven treatment? A nationwide study of US breast cancer patients
BACKGROUND: Tumor size has historically been used to stage breast cancer and guide treatment recommendations. The importance of tumor biology in long-term outcomes is increasingly being acknowledged. No large studies have examined the relative roles of tumor size and receptor status on response to n...
Na minha lista:
| 發表在: | Clin Breast Cancer |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6888946/ https://ncbi.nlm.nih.gov/pubmed/31300338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2019.05.014 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|